These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 39196186)

  • 21. A-Band Titin Truncation in Zebrafish Causes Dilated Cardiomyopathy and Hemodynamic Stress Intolerance.
    Huttner IG; Wang LW; Santiago CF; Horvat C; Johnson R; Cheng D; von Frieling-Salewsky M; Hillcoat K; Bemand TJ; Trivedi G; Braet F; Hesselson D; Alford K; Hayward CS; Seidman JG; Seidman CE; Feneley MP; Linke WA; Fatkin D
    Circ Genom Precis Med; 2018 Aug; 11(8):e002135. PubMed ID: 30354343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rare Variant Genetics and Dilated Cardiomyopathy Severity: The DCM Precision Medicine Study.
    Hofmeyer M; Haas GJ; Jordan E; Cao J; Kransdorf E; Ewald GA; Morris AA; Owens A; Lowes B; Stoller D; Wilson Tang WH; Garg S; Trachtenberg BH; Shah P; Pamboukian SV; Sweitzer NK; Wheeler MT; Wilcox JE; Katz S; Pan S; Jimenez J; Smart F; Wang J; Gottlieb SS; Judge DP; Moore CK; Huggins GS; Kinnamon DD; Ni H; Hershberger RE;
    Circulation; 2023 Sep; 148(11):872-881. PubMed ID: 37641966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Titin-truncating mutations associated with dilated cardiomyopathy alter length-dependent activation and its modulation via phosphorylation.
    Vikhorev PG; Vikhoreva NN; Yeung W; Li A; Lal S; Dos Remedios CG; Blair CA; Guglin M; Campbell KS; Yacoub MH; de Tombe P; Marston SB
    Cardiovasc Res; 2022 Jan; 118(1):241-253. PubMed ID: 33135063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Titin Missense Variants in Dilated Cardiomyopathy.
    Begay RL; Graw S; Sinagra G; Merlo M; Slavov D; Gowan K; Jones KL; Barbati G; Spezzacatene A; Brun F; Di Lenarda A; Smith JE; Granzier HL; Mestroni L; Taylor M;
    J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26567375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Rare Genetic Variants and Early-Onset Atrial Fibrillation in Ethnic Minority Individuals.
    Chalazan B; Mol D; Darbar FA; Ornelas-Loredo A; Al-Azzam B; Chen Y; Tofovic D; Sridhar A; Alzahrani Z; Ellinor P; Darbar D
    JAMA Cardiol; 2021 Jul; 6(7):811-819. PubMed ID: 33950154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Left Ventricular Systolic Dysfunction Among Carriers of Truncating Variants in Filamin C With Frequent Ventricular Arrhythmia and End-stage Heart Failure.
    Akhtar MM; Lorenzini M; Pavlou M; Ochoa JP; O'Mahony C; Restrepo-Cordoba MA; Segura-Rodriguez D; Bermúdez-Jiménez F; Molina P; Cuenca S; Ader F; Larrañaga-Moreira JM; Sabater-Molina M; Garcia-Alvarez MI; Arantzamendi LG; Truszkowska G; Ortiz-Genga M; Ruiz IS; Nielsen SK; Rasmussen TB; Robles Mezcua A; Alvarez-Rubio J; Eiskjaer H; Gautel M; Garcia-Pinilla JM; Ripoll-Vera T; Mogensen J; Limeres Freire J; Rodríguez-Palomares JF; Peña-Peña ML; Rangel-Sousa D; Palomino-Doza J; Arana Achaga X; Bilinska Z; Zamarreño Golvano E; Climent V; Peñalver MN; Barriales-Villa R; Charron P; Yotti R; Zorio E; Jiménez-Jáimez J; Garcia-Pavia P; Elliott PM;
    JAMA Cardiol; 2021 Aug; 6(8):891-901. PubMed ID: 33978673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relevance of truncating titin mutations in dilated cardiomyopathy.
    Akinrinade O; Alastalo TP; Koskenvuo JW
    Clin Genet; 2016 Jul; 90(1):49-54. PubMed ID: 26777568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Titin-truncating variants affect heart function in disease cohorts and the general population.
    Schafer S; de Marvao A; Adami E; Fiedler LR; Ng B; Khin E; Rackham OJ; van Heesch S; Pua CJ; Kui M; Walsh R; Tayal U; Prasad SK; Dawes TJ; Ko NS; Sim D; Chan LL; Chin CW; Mazzarotto F; Barton PJ; Kreuchwig F; de Kleijn DP; Totman T; Biffi C; Tee N; Rueckert D; Schneider V; Faber A; Regitz-Zagrosek V; Seidman JG; Seidman CE; Linke WA; Kovalik JP; O'Regan D; Ware JS; Hubner N; Cook SA
    Nat Genet; 2017 Jan; 49(1):46-53. PubMed ID: 27869827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Pathogenic DNA Variants Predisposing to Cardiomyopathy With Cardiovascular Disease Outcomes and All-Cause Mortality.
    Patel AP; Dron JS; Wang M; Pirruccello JP; Ng K; Natarajan P; Lebo M; Ellinor PT; Aragam KG; Khera AV
    JAMA Cardiol; 2022 Jul; 7(7):723-732. PubMed ID: 35544052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. European ancestry as a risk factor for atrial fibrillation in African Americans.
    Marcus GM; Alonso A; Peralta CA; Lettre G; Vittinghoff E; Lubitz SA; Fox ER; Levitzky YS; Mehra R; Kerr KF; Deo R; Sotoodehnia N; Akylbekova M; Ellinor PT; Paltoo DN; Soliman EZ; Benjamin EJ; Heckbert SR;
    Circulation; 2010 Nov; 122(20):2009-15. PubMed ID: 21098467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poor prognosis of rare sarcomeric gene variants in patients with dilated cardiomyopathy.
    Merlo M; Sinagra G; Carniel E; Slavov D; Zhu X; Barbati G; Spezzacatene A; Ramani F; Salcedo E; Di Lenarda A; Mestroni L; Taylor MR;
    Clin Transl Sci; 2013 Dec; 6(6):424-8. PubMed ID: 24119082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy.
    Eberly LA; Day SM; Ashley EA; Jacoby DL; Jefferies JL; Colan SD; Rossano JW; Semsarian C; Pereira AC; Olivotto I; Ingles J; Seidman CE; Channaoui N; Cirino AL; Han L; Ho CY; Lakdawala NK
    JAMA Cardiol; 2020 Jan; 5(1):83-91. PubMed ID: 31799990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward Genetics-Driven Early Intervention in Dilated Cardiomyopathy: Design and Implementation of the DCM Precision Medicine Study.
    Kinnamon DD; Morales A; Bowen DJ; Burke W; Hershberger RE;
    Circ Cardiovasc Genet; 2017 Dec; 10(6):. PubMed ID: 29237686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Truncating titin mutations are associated with a mild and treatable form of dilated cardiomyopathy.
    Jansweijer JA; Nieuwhof K; Russo F; Hoorntje ET; Jongbloed JD; Lekanne Deprez RH; Postma AV; Bronk M; van Rijsingen IA; de Haij S; Biagini E; van Haelst PL; van Wijngaarden J; van den Berg MP; Wilde AA; Mannens MM; de Boer RA; van Spaendonck-Zwarts KY; van Tintelen JP; Pinto YM
    Eur J Heart Fail; 2017 Apr; 19(4):512-521. PubMed ID: 27813223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enrichment of titin-truncating variants in exon 327 in dilated cardiomyopathy and its relevance to reduced nonsense-mediated mRNA decay efficiency.
    Kim YG; Ha C; Shin S; Park JH; Jang JH; Kim JW
    Front Genet; 2022; 13():1087359. PubMed ID: 36685919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of titin in cardiomyopathy: from DNA variants to patient stratification.
    Ware JS; Cook SA
    Nat Rev Cardiol; 2018 Apr; 15(4):241-252. PubMed ID: 29238064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amino Acid-Level Signal-to-Noise Analysis Aids in Pathogenicity Prediction of Incidentally Identified
    Connell PS; Berkman AM; Souder BM; Pirozzi EJ; Lovin JJ; Rosenfeld JA; Liu P; Tunuguntla H; Allen HD; Denfield SW; Kim JJ; Landstrom AP
    Circ Genom Precis Med; 2021 Feb; 14(1):e003131. PubMed ID: 33226272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association Between Titin Loss-of-Function Variants and Early-Onset Atrial Fibrillation.
    Choi SH; Weng LC; Roselli C; Lin H; Haggerty CM; Shoemaker MB; Barnard J; Arking DE; Chasman DI; Albert CM; Chaffin M; Tucker NR; Smith JD; Gupta N; Gabriel S; Margolin L; Shea MA; Shaffer CM; Yoneda ZT; Boerwinkle E; Smith NL; Silverman EK; Redline S; Vasan RS; Burchard EG; Gogarten SM; Laurie C; Blackwell TW; Abecasis G; Carey DJ; Fornwalt BK; Smelser DT; Baras A; Dewey FE; Jaquish CE; Papanicolaou GJ; Sotoodehnia N; Van Wagoner DR; Psaty BM; Kathiresan S; Darbar D; Alonso A; Heckbert SR; Chung MK; Roden DM; Benjamin EJ; Murray MF; Lunetta KL; Lubitz SA; Ellinor PT;
    JAMA; 2018 Dec; 320(22):2354-2364. PubMed ID: 30535219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Transthyretin Val122Ile Variant With Incident Heart Failure Among Black Individuals.
    Parcha V; Malla G; Irvin MR; Armstrong ND; Judd SE; Lange LA; Maurer MS; Levitan EB; Goyal P; Arora G; Arora P
    JAMA; 2022 Apr; 327(14):1368-1378. PubMed ID: 35377943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mortality Risk Associated With Truncating Founder Mutations in Titin.
    Jansen M; Baas AF; van Spaendonck-Zwarts KY; Ummels AS; van den Wijngaard A; Jongbloed JDH; van Slegtenhorst MA; Lekanne Deprez RH; Wessels MW; Michels M; Houweling AC; Hoorntje ET; Helderman-van den Enden PJTM; Barge-Schaapveld DQCM; Peter van Tintelen J; van den Berg MP; Wilde AAM; Ploos van Amstel HK; Hennekam EAM; Asselbergs FW; Sijbrands EJG; Dooijes D
    Circ Genom Precis Med; 2019 May; 12(5):e002436. PubMed ID: 31112426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.